The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โABBVโ.
The cost to borrow / borrow fee is an annualized percentage an account is charged when borrowing shares of a stock.
Please note that the borrow fee and available shares to borrow displayed on this page are solely based on information provided by Interactive Brokers.
Company | Cost to borrow (% year) | Shares available | Country |
---|---|---|---|
![]() Pfizer PFE | 0.4081% | 10 M | ๐บ๐ธ USA |
![]() Bristol-Myers Squibb BMY | 0.4081% | 10 M | ๐บ๐ธ USA |
![]() Eli Lilly LLY | 0.4081% | 9.1 M | ๐บ๐ธ USA |
![]() Amgen AMGN | 0.4081% | 4.9 M | ๐บ๐ธ USA |
![]() Gilead Sciences GILD | 0.25% | 10 M | ๐บ๐ธ USA |
![]() Biogen BIIB | 0.4081% | 3 M | ๐บ๐ธ USA |
![]() GlaxoSmithKline GSK | 0.5472% | 0.85 M | ๐ฌ๐ง UK |
![]() AstraZeneca AZN | 0.25% | 4.1 M | ๐ฌ๐ง UK |
![]() Neurocrine Biosciences
NBIX | 0.4081% | 1.5 M | ๐บ๐ธ USA |